Decadron (Dexamethasone) Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Decadron (dexamethasone) and are wondering why your pharmacy is having trouble filling it, this update is for you. The availability picture for dexamethasone in 2026 is nuanced — oral tablets are generally widely available, but the injectable form has been in intermittent shortage for over a decade, and the brand-name Decadron tablet has been discontinued entirely. Here's a clear-eyed look at where things stand.

Quick Summary: Dexamethasone Availability in 2026

• Brand-name Decadron tablets: Discontinued in the U.S. Not available under the Decadron brand name.
• Generic dexamethasone oral tablets: Generally widely available at most pharmacies. No major active shortage.
• Dexamethasone oral concentrate / Intensol: Generally available, though fewer pharmacies stock it routinely — may need to be ordered.
• Dexamethasone sodium phosphate injection: Intermittent shortage ongoing — has been on the FDA Drug Shortage Database for over 10 years. Availability varies by location, vial size, and concentration.

Why Has Injectable Dexamethasone Been in Shortage for So Long?

Dexamethasone injection first appeared on FDA's radar as a shortage concern over a decade ago and has remained intermittently listed since. This is a structural problem, not a simple supply blip. The core issues include:

• Manufacturing complexity: Sterile injectable drugs require specialized cleanroom facilities and rigorous quality control. Even small manufacturing disruptions can have outsized supply impacts.
• Limited manufacturer base: Only a small number of manufacturers produce dexamethasone injection in the U.S. When one experiences a production issue, the entire supply can tighten.
• Thin profit margins: Generic injectable drugs are not highly profitable, reducing the economic incentive for manufacturers to expand capacity or for new competitors to enter the market.
• COVID-19 demand spike: In 2020, the RECOVERY trial showed dexamethasone saved lives in severely ill COVID-19 patients, causing a global demand surge that strained supply chains. These effects continued to ripple through 2021-2022 and the supply chain has not fully normalized.

How Is 2026 Different from Prior Years?

The overall U.S. drug shortage landscape improved in 2025-2026. As of February 2026, the total number of active drug shortages dropped to approximately 195, down from 323 at the start of 2024. Dexamethasone tablets have benefited from this improved environment and are generally accessible. However, injectable dexamethasone remains among the drugs that have been in shortage for over a decade, reflecting stubborn structural supply chain issues that persist despite better overall conditions.

What Should Patients Do Right Now?

If you take oral dexamethasone regularly, here are practical steps to protect your supply:

1. Refill early. Don't wait until your last few tablets. Refill when you have 7-10 days remaining to give yourself time to resolve any stock issues.
2. Ask about a 90-day supply. Many plans cover 90-day fills through mail-order at a lower copay, and this reduces how often you deal with potential supply gaps.
3. Use medfinder. medfinder calls pharmacies near you to check real-time availability of your specific medication and dosage, saving you hours of phone calls.
4. Have a backup plan. Talk to your doctor proactively about which alternative corticosteroid you could switch to if dexamethasone becomes unavailable, so you're not scrambling during a flare.
5. Try independent pharmacies. They often have different distributors and may have stock when chain pharmacies don't.

What Taper Pack Issues Should I Know About?

Dexamethasone taper packs (marketed as TaperDex, Dexabliss, and Dxevo in various day-lengths) may face sporadic availability issues even when individual tablets are available. If your taper pack isn't in stock, ask your doctor if they can write a prescription for individual tablets in the exact quantities needed — this achieves the same taper regimen and is often less expensive.

Where Can I Track the Dexamethasone Shortage?

The FDA Drug Shortage Database (accessdata.fda.gov) is the authoritative source for active shortage listings. ASHP (American Society of Health-System Pharmacists) also maintains a Drug Shortage Resource Center. For patient-facing tips, see our guides on why dexamethasone is hard to find and how to find it in stock near you.